Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VIC Library | Available |
"Strategies to Mitigate the Toxicity of Cancer Therapeutics, Volume 155 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters, each of which is written by an international board of authors. Provides the authority and ex…
Table of Contents:; 1. HISTORY OF IMMUNOTHERAPY -- 2. PRINCIPLES OF IMMUNOLOGY AND IMMUNOTHERAPY -- 3. CYTOKINES IN IMMUNOTHERAPY -- 4. IMMUNE CHECKPOINT INHIBITORS -- 5. BACILLUS CALMETTE-GUÉRIN - 6. ORAL IMMUNOMODULATORY AGENTS --7. ACTIVE IMMUNITY: VACCINE THERAPY -- 8. PASSIVE/ADOPTIVE IMMUNOTH…
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency SUR Library Missing | Available | ||
c.2 BC Cancer Agency SUR Library | Available | ||
c.3 BC Cancer Agency VAN Library Missing | Available | ||
c.4 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.5 BC Cancer Agency VAN Library Missing | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.2 BC Cancer Agency ARHCC Library Missing | Available | ||
c.3 BC Cancer Agency ARHCC Library | Available | ||
c.2 BC Cancer Agency CN Library | Available | ||
c.3 BC Cancer Agency CN Library | Available | ||
c.3 BC Cancer Agency KEL Library | Available | ||
c.3 BC Cancer Agency SUR Library | Available | ||
c.2 BC Cancer Agency VIC Library Missing | Available | ||
c.4 BC Cancer Agency VIC Library | Available | ||
c.5 BC Cancer Agency VIC Library | Available | ||
c.5 BC Cancer Agency SUR Library | Available | ||
c.4 BC Cancer Agency KEL Library | On Loan, due Wednesday, May 15, 2024 | ||
c.1 BC Cancer Agency VAN Library | On Loan, due Tuesday, June 11, 2024 | ||
c.2 BC Cancer Agency VAN Library | On Loan, due Thursday, May 23, 2024 | ||
c.2 BC Cancer Agency KEL Library | On Loan, due Monday, June 17, 2024 | ||
c.4 BC Cancer Agency SUR Library | On Loan, due Monday, June 10, 2024 | ||
c.3 BC Cancer Agency VIC Library | On Loan, due Wednesday, June 5, 2024 | ||
c.5 BC Cancer Agency KEL Library | On Loan, due Monday, March 25, 2024 |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Contents:; 1: Basis of Carcinogenesis; 2: Epidemiology and Prevention; 3: Evidence-Based Nursing in Basic Anticancer Treatment: Management of the Most Important Side Effects; 4: The Patients? Journey with Targeted Therapies; 5: Immunotherapy: New Challenges for Nursing; 6: Robotic Surgery; 7: Relat…
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.2 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency CN Library Missing | Available | ||
c.2 BC Cancer Agency SUR Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available |
Contents:; Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and target…
The series is primarily intended to document the disease classifications used in the Population Health Impact of Disease in Canada (PHI) research program and help researchers to understand how the PHI estimates were calculated. It is also of interest to health professionals, advocacy groups, and in…
c.1 BC Cancer Agency VAN Library | Available |